Cargando…
Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium
Intrauterine progestin is a treatment option for women with atypical hyperplasia or low-risk endometrial cancer who wish to preserve their fertility, or whose poor surgical fitness precludes safe hysterectomy. We hypothesized that in such women with obesity, weight loss during progestin treatment ma...
Autores principales: | Barr, Chloe E., Ryan, Neil A.J., Derbyshire, A.E., Wan, Y. Louise, MacKintosh, Michelle L., McVey, Rhona J., Bolton, James, Fitzgerald, Cheryl, Awad, Dina, Slade, Richard J., Syed, Akheel A., Ammori, Basil J., Crosbie, Emma J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306269/ https://www.ncbi.nlm.nih.gov/pubmed/34348914 http://dx.doi.org/10.1158/1940-6207.CAPR-21-0229 |
Ejemplares similares
-
The impact of obesity and bariatric surgery on the immune microenvironment of the endometrium
por: Naqvi, Anie, et al.
Publicado: (2021) -
The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk
por: MacKintosh, Michelle L., et al.
Publicado: (2018) -
Women’s Risk Perceptions and Willingness to Engage in Risk-Reducing Interventions for the Prevention of Obesity-Related Endometrial Cancer
por: Derbyshire, Abigail E, et al.
Publicado: (2022) -
Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer
por: Behrouzi, Roya, et al.
Publicado: (2020) -
BRCA and lynch syndrome-associated ovarian cancers behave differently
por: Ryan, Neil A.J., et al.
Publicado: (2017)